ABVC Biopharma Inc
General ticker "ABVC" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $6.4M
ABVC Biopharma Inc does not follow the US Stock Market performance with the rate: -42.8%.
Estimated limits based on current volatility of 4.8%: low 0.48$, high 0.53$
Factors to consider:
- Current price 39.9% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.88$, 3.19$]
- 2024-12-30 to 2025-12-30 estimated range: [1.12$, 3.36$]
Financial Metrics affecting the ABVC estimates:
- Negative: Non-GAAP EPS, $ of -2.45 <= 0.10
- Negative: Operating profit margin, % of -98.18 <= 1.03
- Negative: Operating cash flow per share per price, % of -43.52 <= 2.35
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Negative: 0.14 < Interest expense per share, $ of 0.58
Short-term ABVC quotes
Long-term ABVC plot with estimates
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $0.36MM | $0.97MM | $0.15MM |
Operating Expenses | $12.06MM | $16.08MM | $8.37MM |
Operating Income | $-11.71MM | $-15.11MM | $-8.22MM |
Non-Operating Income | $0.50MM | $-0.40MM | $-2.44MM |
Interest Expense | $0.23MM | $0.29MM | $2.49MM |
R&D Expense | $1.00MM | $2.69MM | $1.06MM |
Income(Loss) | $-11.21MM | $-15.51MM | $-10.65MM |
Taxes | $0.83MM | $0.80MM | $-0.14MM |
Profit(Loss) | $-12.04MM | $-16.31MM | $-10.52MM |
Stockholders Equity | $8.84MM | $3.10MM | $8.39MM |
Inventory | $0.03MM | $1.31MM | $0.00MM |
Assets | $13.70MM | $9.86MM | $14.49MM |
Operating Cash Flow | $-7.60MM | $-7.40MM | $-4.24MM |
Capital expenditure | $0.02MM | $0.12MM | $0.02MM |
Investing Cash Flow | $-0.81MM | $-1.72MM | $-0.36MM |
Financing Cash Flow | $10.00MM | $4.01MM | $3.92MM |
Earnings Per Share* | $-4.80 | $-5.15 | $-2.43 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.